Literature DB >> 3257669

Q fever endocarditis on porcine bioprosthetic valves. Clinicopathologic features and microbiologic findings in three patients treated with doxycycline, cotrimoxazole, and valve replacement.

M L Fernández-Guerrero1, J M Muelas, J M Aguado, G Renedo, J Fraile, F Soriano, E De Villalobos.   

Abstract

Three patients developed Q fever endocarditis on porcine bioprosthetic valves. They had a subacute or chronic course with nonspecific symptoms, enlargement of the liver and spleen, and cardiac failure due to destruction of the cusps, without disruption of the valve ring. High-phase I-specific IgG and IgA antibody titers against Coxiella burnetii were found. C. burnetii was isolated in each patient by inoculating suspensions of valve tissue into a human fetal diploid fibroblast cell line, which was grown as monolayers on slides contained inside rubber-stoppered tube cultures. Patients were treated successfully with doxycycline, cotrimoxazole, and valve replacement and were followed up for periods of 24 to 42 months; no evidence of deterioration was found. The human fetal diploid cell culture may be an expeditious, easy, and safe method to isolate C. burnetii from cardiac valves. Valve replacement seemed necessary to cure prosthetic-valve endocarditis due to C. burnetii infection. Combined therapy with doxycycline and cotrimoxazole may control the disease and prevent reinfection of the homografts replacing the valves.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257669     DOI: 10.7326/0003-4819-108-2-209

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.

Authors:  P Y Levy; M Drancourt; J Etienne; J C Auvergnat; J Beytout; J M Sainty; F Goldstein; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 2.  Treatment of Q fever.

Authors:  D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study.

Authors:  P Y Lovey; A Morabia; D Bleed; O Péter; G Dupuis; J Petite
Journal:  BMJ       Date:  1999-07-31

4.  Role of C1q in phagocytosis of Salmonella minnesota by pulmonary endothelial cells.

Authors:  U S Ryan; D R Schultz; J D Goodwin; J M Vann; M P Selvaraj; M A Hart
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Serological differentiation between acute (late control) and endocarditis Q fever.

Authors:  F Soriano; M T Camacho; C Ponte; P Gómez
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

6.  Isolation of Coxiella burnetii from heart valves of patients treated for Q fever endocarditis.

Authors:  K Mühlemann; L Matter; B Meyer; K Schopfer
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

Review 7.  Q fever.

Authors:  L G Reimer
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Q fever endocarditis: diagnostic approaches and monitoring of therapeutic effects.

Authors:  O Péter; M Flepp; G Bestetti; J Nicolet; R Lüthy; G Dupuis
Journal:  Clin Investig       Date:  1992-10

9.  Conventional viral cultures and shell vial assay for diagnosis of apparently culture-negative Coxiella burnetii endocarditis.

Authors:  R Gil-Grande; J M Aguado; C Pastor; M García-Bravo; C Gómez-Pellico; F Soriano; A R Noriega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

10.  Q fever - a review.

Authors:  T J Marrie
Journal:  Can Vet J       Date:  1990-08       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.